Applications

Sacubitril/valsartan, sold under the brand name Entresto, is a fixed-dose combination medication for use in heart failure. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan. The combination is sometimes described as an "angiotensin receptor-neprilysin inhibitor" (ARNi). It is recommended for use as a replacement for an ACE inhibitor or an angiotensin receptor blocker in people with heart failure with reduced ejection fraction.

Potential side effects include angioedema, kidney problems, and low blood pressure.

It was approved for medical use.

Packaging

20kg/drum

Technical specification

In-house standard

On a small screen, scroll the technical table horizontally.

Published reference specifications. Confirm the current grade, SDS / TDS / COA, packaging and delivery terms with your quotation.